Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma

NCT01939327

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Institut Paoli-Calmettes Marseille, France

View Trial Details

Completed

A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early

NCT02741999

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Tufts Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

NCT01982539

Conditions: Acute Pain, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Sheffield, Alabama, United States

Stanford, California, United States

View Trial Details

Completed

Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)

NCT02303522

Conditions: B-cell Precursor Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Research Site Vienna, Austria

Research Site Berlin, Germany

Research Site Roma, Italy

View Trial Details

Completed

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

NCT01490723

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pembrolizumab (MK-3475) in MM Patients With Residual Disease

NCT02636010

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital Germans Trias i Pujol Badalona, Spain

Hospital Clinic Barcelona, Spain

Hospital 12 de octubre Madrid, Spain

Hospital Ramón y Cajal Madrid, Spain

View Trial Details

Completed

ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)

NCT00662948

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Hospital Juan Canalejo A Coruña, Spain

Hospital de Alcorcón Alcorcón, Spain

Hospital germans Trias i Pujol Badalona, Spain

Hospital Clínic Barcelona, Spain

View all 21 locations

View Trial Details

Completed

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

NCT02316197

Conditions: Advanced Solid Tumors, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations: Institut Jules Bordet Brussels, Belgium

UZ Leuven Leuven, Belgium

Rigshospitalet - Onkologisk KFE Copenhagen, Denmark

Herlev Hospital University of Copenhagen Herlev, Denmark

View Trial Details

Completed

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

NCT01916135

Conditions: Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

NCT02783651

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Tucson, Arizona, United States

Research Site Duarte, California, United States

Research Site Los Angeles, California, United States

Research Site Chicago, Illinois, United States

View all 19 locations

View Trial Details